Table 2. FGFR1/FOXM1/MELK/GLI2/ZEB1/TWIST1 set is a strong prognostic factor independently of clinical and biological parameters.
HR | p-value | 95% Cl | |
---|---|---|---|
Risk Score High vs Low | 2.82 | 6.9e-05 | [1.69–4.68] |
Karno ≥ 70 | 0.82 | 0.521 | [0.44–1.51] |
Tumor resection vs others | 1.70 | 0.070 | [0.96–3.04] |
Age ≥ 60 | 1.12 | 0.657 | [0.68–1.84] |
Mesenchymal vs Classical | 1.17 | 0.617 | [0.63–2.18] |
Neural vs Classical | 0.79 | 0.499 | [0.40–1.56] |
Proneural vs Classical | 1.02 | 0.952 | [0.47–2.24] |
Non G-CIMP vs G-CIMP | 2.23 | 0.129 | [0.79–6.28] |
MGMT methylated vs non methylated | 0.54 | 0.011 | [0.33–0.87] |